Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicorandil in Type 2 Diabetic Obese Patients
NCT06423729Phase 2Completed
- Sponsor
- Tanta University
- Start
- Nov 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicorandil in type 2 diabetes mellitus (T2DM), sponsored by Tanta University. Started Nov 2023; status: completed.
02
Drugs
nicorandil
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06423729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06423729.